Clinical Trials Browser

Unknown × Myelodysplastic Syndromes × Granulocyte Colony-Stimulating Factor × Clear all

NCT03356080 2017-11-29

DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute